Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Description

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.

Conditions

Gastro Esophageal Reflux Disease, Barrett Esophagus

Study Overview

Study Details

Study overview

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests: A Discrete Choice-Based Conjoint Analysis

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Condition
Gastro Esophageal Reflux Disease
Intervention / Treatment

-

Contacts and Locations

Aurora

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States, 80045

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provision to sign and date the consent form.
  • * Stated willingness to comply with all study procedures and be available for the duration of the study.
  • * Individual has 3 or more established risk factors for BE (age \> 50 years, chronic GERD, male, white race, smoking, obesity, family history of BE/EAC).
  • * Unable to consent.
  • * Prior diagnosis of BE/EAC.
  • * Life limiting comorbidity/ disability.
  • * Active dementia/ cognitive impairment.
  • * Incarcerated.

Ages Eligible for Study

18 Years to 89 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Colorado, Denver,

Sachin Wani, MD, PRINCIPAL_INVESTIGATOR, University of Colorado - Anschutz Medical Campus

Jennifer Kolb, MD, MS, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Study Record Dates

2029-03-01